Market Research Reports - Research and Markets

Welcome - Register - Login - Help/FAQ - 0 items

Search
Enter keywords, a title or
a report id number below.


	Select a currency for use throughout the site

Search Results

Your Search for 'Anxiety Disorders - A Decade of Declining Revenues' returned 3 results - Page 1 of 1

Psychopharmacotherapy Market Insights: Obstacles and Opportunities in Mood Disorders and Cognitive Impairment, 2005-2012
Spectra Intelligence, Nov 2005, Pages: 91 Examines the global mood disorder sector and highlights the converging market stimulators and inhibitors that may lead to a market decline from an estimated US$17.4 billion in 2005 to US$15 billion

Antiageing and Life Enhancement Pharmacotherapeutics: Rejuvenating Drug Markets To 2012 and Beyond
Spectra Intelligence, Jan 2006, Pages: 580 , and the Central Nervous System Depression Prevalence Aetiology of Depression Types of Depression Major depression Dysthymia Bipolar Disorder Symptoms of Depression Anxiety Disorders Prevalence Addiction

The World Market for Gynaecology, 2007-2017
Spectra Intelligence, Sep 2007, Pages: 350 decade will be exciting, but companies will need to differentiate their products and consider the market forces that may affect product revenue and portfolios. The World Market for Gynaceology aims

Results:

First -

Prev -

1 -

Next -

Last

For enquiries please call us on:

+353-1-415-1241 (GMT Office Hours)

1-800-526-8630 (US/Canada Toll Free)

1-917-300-0470 (EST Office Hours)